UPClytics
DeutschEnglish
AnmeldenRegistrieren
Alle Fälle anzeigen

UPC CoA 899/2025

31. Okt. 2025·EP4344633 +1 more: ANALYTE SENSOR METHODS

Verfahrensdetails
Status
Oral Phase
Verfahrensart
Berufung
Kategorie
Hauptberufung
Parteien
Kläger
Vertreter: Christian Dekoninck (Taylor Wessing)
Beklagte
Vertreter: Tjibbe Douma (Bird & Bird (Netherlands) LLP); Edoardo Barbera (Bird & Bird Società tra Avvocati S.r.l.)
Division
Court of Appeal
Richter
Technology
Pharmaceutical & Medical
Sprache
English
Erste Entscheidung
30. März 2026
Ansprüche
Streitig1, 15
Verletzt1, 15
Hinweise: Infringement findings are on a 'more likely than not' basis for purposes of provisional measures only; not a final merits determination. Validity grounds (added matter, sufficiency, novelty, inventive step) were raised by Appellants but found not more likely than not to invalidate claims 1 and 15.
Entscheidungen
  • 2026-03-30
    PI erteiltBerufungsentscheidungAppeal RoP220.1

    The Court of Appeal dismissed the appeal and upheld the first-instance preliminary injunction prohibiting Sinocare Inc. and A. Menarini Diagnostics from manufacturing, marketing, placing on the market, using, supplying, or importing the GlucoMen iCan CGM product in the UPC territory. The Court found it more likely than not that claims 1 and 15 of EP 4 344 633 are infringed and not invalid. Appellants were ordered to pay an interim award of costs of EUR 200,000.

    Rechtsfragen:Jurisdiction over Chinese defendant (Sinocare Inc.) based on Art. 71b(2) Brussels I Recast and Art. 7(2) BRWaiver of jurisdiction challenge on appeal for Appellant 2 (Art. 26(1) Brussels I Recast, R. 19.7 RoP)Claim construction of 'sensor assembly' as pre-assembled unit (feature 1.1)Claim construction of 'distal surface' of support (feature 1.4)Claim construction of seal 'shaped to enclose the contacts portion within the support' (feature 1.6)Infringement of claims 1 and 15 by GlucoMen iCanValidity — added matter, sufficiency, novelty and inventive step (all rejected at preliminary stage)Urgency of provisional measures applicationBalance of interests / necessity of provisional measuresScope of generally worded injunction (exclusion of Sinocare iCan i3)Skilled person definition as question of law not fact (R. 171.2 RoP)Costs — interim award at 50% of applicable ceiling (EUR 200,000)
Dokumente
DokumenttitelDatumÖffentlich
action.communication.general2026-04-21Nicht öffentlich
Other Documents2026-04-10Nicht öffentlich
action.issueOrder.order2026-04-10Nicht öffentlich
Order2026-04-10Öffentlich
Receipt2026-04-03Nicht öffentlich
Cover sheet2026-04-03Nicht öffentlich
Application Respondent2026-04-03Nicht öffentlich
action.phaseChange.caseClose2026-03-30Nicht öffentlich
action.issueDecision.decision2026-03-30Nicht öffentlich
Final Order2026-03-30Öffentlich
action.phaseChange.oralPhaseClose2026-02-10Nicht öffentlich
Note2026-02-10Nicht öffentlich
action.issueOrder.order2026-02-04Nicht öffentlich
Order2026-02-04Öffentlich
Receipt2026-02-04Nicht öffentlich
Cover sheet2026-02-04Nicht öffentlich
Application document Appellant2026-02-04Nicht öffentlich
action.issueOrder.order2026-02-04Nicht öffentlich
Order2026-02-04Öffentlich
Receipt2026-02-03Nicht öffentlich
Cover sheet2026-02-03Nicht öffentlich
Application document Respondent2026-02-03Nicht öffentlich
action.issueOrder.order2026-02-02Nicht öffentlich
Order2026-02-02Öffentlich
Receipt2026-01-30Nicht öffentlich
Cover sheet2026-01-30Nicht öffentlich
Document2026-01-30Nicht öffentlich
action.issueOrder.order2026-01-29Nicht öffentlich
Order2026-01-29Öffentlich
Receipt2026-01-29Nicht öffentlich
Cover sheet2026-01-29Nicht öffentlich
Document2026-01-29Nicht öffentlich
Document2026-01-29Nicht öffentlich
Document2026-01-29Nicht öffentlich
action.communication.general2026-01-21Nicht öffentlich
action.communication.general2026-01-15Nicht öffentlich
action.phaseChange.oralPhaseOpen2026-01-14Nicht öffentlich
action.phaseChange.writtenPhaseClose2026-01-14Nicht öffentlich
action.issueOrder.order2026-01-09Nicht öffentlich
Order2026-01-09Öffentlich
action.summons.oralHearing2025-12-11Nicht öffentlich
Summons2025-12-11Öffentlich
action.communication.general2025-12-05Nicht öffentlich
Cover sheet2025-12-03Nicht öffentlich
Other document Respondent2025-12-03Nicht öffentlich
Receipt2025-12-03Nicht öffentlich
Cover sheet2025-12-02Nicht öffentlich
Other document Appellant2025-12-02Nicht öffentlich
Receipt2025-12-02Nicht öffentlich
Note2025-12-01Nicht öffentlich
Other document Respondent2025-11-28Nicht öffentlich
Cover sheet2025-11-28Nicht öffentlich
Other document Respondent2025-11-28Nicht öffentlich
Other document Respondent2025-11-28Nicht öffentlich
Receipt2025-11-28Nicht öffentlich
action.communication.general2025-11-28Nicht öffentlich
action.issueOrder.order2025-11-26Nicht öffentlich
Order2025-11-26Öffentlich
action.communication.general2025-11-25Nicht öffentlich
Other Documents2025-11-25Nicht öffentlich
Exhibit document Respondent2025-11-21Nicht öffentlich
Cover sheet2025-11-21Nicht öffentlich
Exhibit document Respondent2025-11-21Nicht öffentlich
Exhibit document Respondent2025-11-21Nicht öffentlich
Exhibit document Respondent2025-11-21Nicht öffentlich
Exhibit document Respondent2025-11-21Nicht öffentlich
Exhibit document Respondent2025-11-21Nicht öffentlich
Exhibit document Respondent2025-11-21Nicht öffentlich
Other document Respondent2025-11-21Nicht öffentlich
Statement of Response2025-11-21Nicht öffentlich
Other document Respondent2025-11-21Nicht öffentlich
Receipt2025-11-21Nicht öffentlich
action.publishOrderDecision.case2025-11-06Nicht öffentlich
Cover sheet2025-10-31Nicht öffentlich
Fee2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Exhibit document Appellant2025-10-31Nicht öffentlich
Proof of payment2025-10-31Nicht öffentlich
Statement of appeal and statement of the grounds of appeal2025-10-31Nicht öffentlich
Receipt2025-10-31Nicht öffentlich
Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.

  • UPC has jurisdiction over Sinocare Inc. (China) because by manufacturing and preparing products intended for European market and being actively involved in European marketing, there was a likelihood of damage in UPC Contracting Member States

    KlägerRechtsgrundlage: Art. 71b(2) and Art. 7(2) Brussels I Recast; Art. 33(1)(a) UPCA

  • GlucoMen iCan sensor assembly is a pre-assembled unit comprising sensor, seal, support and sharp, satisfying feature 1.1

    KlägerRechtsgrundlage: Art. 69 EPC; claim 1 of EP 4 344 633

  • 'Distal surface' in feature 1.4 means surface away from user's hand in direction of patient's skin, not necessarily configured to be placed on skin; does not require uninterrupted surface

    KlägerRechtsgrundlage: Art. 69 EPC; claim 1 of EP 4 344 633

  • Feature 1.6 does not require seal to surround contacts portion on both sides; enclosing on one side is sufficient; seal may extend outside support and perform sealing after mating with electronics assembly

    KlägerRechtsgrundlage: Art. 69 EPC; claim 1 of EP 4 344 633

  • Application was filed urgently — filed one month after patent grant and two weeks after unitary effect registration; preparatory work was reasonable

    KlägerRechtsgrundlage: R. 211.4 RoP; R. 206.2 RoP

  • Respondent faces irreparable harm from price erosion in CGM market (both cash pay and reimbursement segments) justifying provisional measures

    KlägerRechtsgrundlage: Art. 62 UPCA; R. 211.1 and 211.3 RoP

  • Generally worded preliminary injunction is appropriate in absence of special circumstances when infringement of a specific embodiment is established

    KlägerRechtsgrundlage: Art. 62 UPCA; R. 211 RoP
Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.

  • Appellant 2 did not contest jurisdiction in first instance but attempts to raise lack of jurisdiction on appeal; this opportunity was foregone

    BeklagterRechtsgrundlage: Art. 26(1) Brussels I Recast; R. 19.7 RoP

  • Skilled person definition is a statement of fact (R. 171.2 RoP) and LD was bound by uncontested definition proposed by Appellants

    BeklagterRechtsgrundlage: R. 171.2 RoP

  • 'Sensor assembly' in feature 1.1 means only a group of parts capable of working together, not necessarily a pre-assembled unit

    BeklagterRechtsgrundlage: Art. 69 EPC; claim 1 of EP 4 344 633

  • 'Distal surface' requires a surface facing towards and placed on the patient's skin; must be uninterrupted

    BeklagterRechtsgrundlage: Art. 69 EPC; claim 1 of EP 4 344 633

  • Feature 1.6 requires seal to surround contacts portion on both sides; limited to embodiment of Figures 34-35

    BeklagterRechtsgrundlage: Art. 69 EPC; claim 1 of EP 4 344 633

  • Application lacked urgency because Respondent was aware of the product since December 2024 and the GlucoMen iCan was technically identical to Sinocare iCan i3 already on market since October 2023

    BeklagterRechtsgrundlage: R. 211.4 RoP

  • Appellants would suffer substantial harm (loss of guarantees, contract damages, potential blacklisting) from preliminary injunction outweighing Respondent's interests

    BeklagterRechtsgrundlage: Art. 62(2) UPCA; R. 211.3 RoP

  • Injunction scope should be strictly limited to GlucoMen iCan o3 or to reimbursement market only

    BeklagterRechtsgrundlage: Art. 62 UPCA

  • Delivery up of GlucoMen iCan products in stock is disproportionate as they may expire before final merits determination

    BeklagterRechtsgrundlage: Art. 62 UPCA; R. 211 RoP